Skip to main content

Advertisement

Table 2 Crude efficacy (not PCR-adjusted), number and quotients of failures by Day and drug categories within 28 days*

From: Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

  artesunate amodiaquine combinations Other ACT non-ACT
Day of censure Failure (n) Total follow-up Quotient Day(x) Free of failure Failure (n) Total follow-up Quotient Day(x) Free of failure Failure (n) Total follow-up Quotient Day(x) Free of failure
0 77 5942 0.013 987 8 2769 0.003 997 11 2926 0.004 996
1 24 5839 0.004 983 8 2746 0.003 994 16 2912 0.005 991
2 4 5806 0.001 982 3 2736 0.001 993 22 2895 0.008 983
3 1 5774 0.000 982 1 2729 0.000 993 24 2868 0.008 975
7 5 5745 0.001 981 2 2720 0.001 992 86 2824 0.030 945
14 103 5675 0.018 964 22 2700 0.008 984 228 2703 0.084 866
21 531 5477 0.097 871 147 2653 0.055 929 491 2419 0.203 690
28 490 4874 0.101 783 260 2479 0.105 832 360 1895 0.190 559
Total 1235 5942    451 2769    1238 2926   
  1. *Note: this table does not refer to randomized comparative trials therefore direct comparisons between drug categories in this table are not legitimate. ACT: artemisinin combination therapy.